Telmitel M25 Tablet 10's
₹118.8*
MRP ₹132
10% off
₹112*
MRP ₹132
15% CB
₹20 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Telmitel M25 Tablet belongs to the class of antihypertensive agents used to treat hypertension (high blood pressure). Hypertension is a condition in which the blood exerts increased pressure on the walls of blood vessels leading to high blood pressure. Symptoms include headache, dizziness, nosebleeds, changes in vision, chest pain, weakness and dyspnea (shortness of breath).
Telmitel M25 Tablet contains Metoprolol tartrate (beta-blocker) and telmisartan (angiotensin receptor blocker). Metoprolol tartrate reduces blood pressure by allowing the blood to flow more smoothly. Telmisartan works by blocking the angiotensin II receptor, relaxing the blood vessels and lowering the blood pressure. Together, Telmitel M25 Tablet helps in reducing the raised blood pressure.
You are advised to take Telmitel M25 Tablet for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, you may experience certain common side-effects such as increased potassium level in the blood (hyperkalemia), headache, nausea, dizziness, weakness, and slow heart rate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not take Telmitel M25 Tablet if you are pregnant as it may cause fetal harm. Consult your doctor before taking Telmitel M25 Tablet if you are breastfeeding. Telmitel M25 Tablet is not recommended for children as efficacy and safety have not been established. Telmitel M25 Tablet may cause dizziness, so drive with caution. Avoid consuming alcohol with Telmitel M25 Tablet as it might cause increased dizziness. Inform your doctor about all the medicines you are taking and your health condition to rule out any interactions.
Telmitel M25 Tablet is a combination of two blood pressure-lowering medicines: Metoprolol tartrate and Telmisartan. Metoprolol tartrate belongs to the class of drugs known as beta-blockers which reduces blood pressure by allowing the blood to flow more smoothly. Telmisartan belongs to the class of drugs called Angiotensin II receptor antagonists that works by blocking the angiotensin II receptor, relaxing the blood vessels and lowering the blood pressure. Together, Telmitel M25 Tablet helps in reducing the raised blood pressure.
Headache
Nausea
Weakness
Slow pulse
Dizziness
Cramps
Cold extremities
Hypotension (lowered BP)
Inform your doctor if you are allergic to any of the contents. Keep your doctor informed if you have kidney or liver diseases. Discuss with your doctor if you are taking any other medicines along with Telmitel M25 Tablet . Consult your doctor if you are pregnant or breastfeeding. Telmitel M25 Tablet is not recommended for children as safety and effectiveness have not been established. Telmitel M25 Tablet may cause dizziness and drowsiness, so drive and operate heavy machinery only if you are alert.
Drug-Drug Interactions: Telmitel M25 Tablet may have interaction with pain killers (aspirin, ibuprofen), anti-seizure (pregabalin), heart-related medicines (digoxin, flecainide), anti-depression drugs (lithium, fluvoxamine, sertraline, fluoxetine), and drugs used to treat erectile dysfunction (sildenafil).
Drug-Food Interactions: Avoid smoking and alcohol consumption.
Drug-Disease Interactions: Inform your doctor if you have diabetes, renal dysfunction (kidney disease), pulmonary disease, alcoholism, congestive heart failure (heart disease), hypotension (low blood pressure) and liver disease.
Limit the intake of salt in your diet.
Cut back on foods that are high in fat and cholesterol. Eat more fruits, vegetables and whole-grain foods.
Avoid tobacco use. Inform your doctor in case of marijuana use.
Dress warmly, as Telmitel M25 Tablet may cause cold extremities.
Maintain low salt and low-fat diet while taking Telmitel M25 Tablet .
Regularly monitor blood pressure levels to prevent hypotension (low blood pressure).
Get up slowly while rising from lying or sitting position as Telmitel M25 Tablet may cause dizziness.
Prolonged intake of Telmitel M25 Tablet can cause the altered potassium level so, regular monitoring of potassium is required.
Hypertension: The blood exerts increased pressure on the walls of blood vessels leading to hypertension. This condition can lead to hardened arteries (blood vessels), decreasing the blood and oxygen flow to the heart. Raised blood pressure can cause chest pain (angina) and heart attack (when blood supply to the heart is blocked). Additionally, high blood pressure also causes brain damage (stroke) and kidney failure. Symptoms of high blood pressure include headache, dizziness, nose bleed, changes in vision, chest pain, weakness and dyspnoea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Telmitel M25 Tablet to avoid unpleasant side-effects. Alcohol intake might interfere with the working of Telmitel M25 Tablet . It might decrease the blood pressure than normal leading to low blood pressure.
Pregnancy
Unsafe
It is not recommended to take Telmitel M25 Tablet while you are pregnant as it may cause foetal harm. Please consult your doctor if you have any concerns.
Breast Feeding
Caution
Please consult your doctor. Your doctor will decide whether Telmitel M25 Tablet can be taken by breastfeeding mothers or not.
Driving
Caution
Telmitel M25 Tablet may cause dizziness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
Dose adjustment may be needed. Telmitel M25 Tablet should be used with caution in patients with liver impairment/liver disease.
Kidney
Caution
Dose adjustment may be needed. Telmitel M25 Tablet should be used with caution in patients with kidney impairment/kidney disease.
Children
Unsafe
Telmitel M25 Tablet is not recommended for children below 18years as the safety and effectiveness have not been established.
Country of origin
We provide you with authentic, trustworthy and relevant information
Product Substitutes